Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 19, 2026Reported sale · Form 4Aimee J. Lenar, President, US Pharma · $258.9KOpen the filing ↗
- Aug 19, 2026Notice of sale · Form 144Lenar Aimee J. · Officer · $258.9KOpen the filing ↗
- Jul 30, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record2,04911 flagged findings
Reported transactions (Form 4)43since Mar 2, 2023 · and 3 other holdings
Corporate events (8-K)30since Mar 1, 2023
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-07-30capital return (buybacks/dividends)freshOpen filing ↗“…included in our Annual Report on Form 10-K for the year ended December 31, 2025. Item 2. Unregistered Sales of Equity Securities…”
+1 more passage from the same document
- “…in our Annual Report on Form 10-K for the year ended December 31, 2025. Item 2. Unregistered Sales of Equity Securities and Use…”
- 2026-04-30capital return (buybacks/dividends)recentOpen filing ↗“…included in our Annual Report on Form 10-K for the year ended December 31, 2025. Item 2. Unregistered Sales of Equity Securities and…”
+1 more passage from the same document
- “…in our Annual Report on Form 10-K for the year ended December 31, 2025. Item 2. Unregistered Sales of Equity Securities and Use…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 2,049)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Aug 19, 26Form 144 ↗Notice of proposed sale
- Jul 30, 2610-Q ↗Quarterly report
- Jul 29, 268-K ↗Current report · Results
- Jul 1, 268-K ↗Current report · A senior executive left or was appointed
Insider transaction · 10 Form 4 filingsshow all 10hide
- May 26, 26Form 4 ↗Insider transaction
- May 26, 26Form 4 ↗Insider transaction
- May 26, 26Form 4 ↗Insider transaction
- May 26, 26Form 4 ↗Insider transaction
- May 26, 26Form 4 ↗Insider transaction
- May 26, 26Form 4 ↗Insider transaction
- May 26, 26Form 4 ↗Insider transaction
- May 26, 26Form 4 ↗Insider transaction
- May 26, 26Form 4 ↗Insider transaction
- May 20, 26Form 4 ↗Insider transaction
- May 20, 26Form 3 ↗Insider transaction
2,049 filings on record, the oldest from May 22, 96.
Listing the 25 most recent filings of the 2,049 on record.
910471
- Jul 1, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Mar 2, 26A senior executive left or was appointed8-K 5.02 ↗
- Jan 2, 26Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Dec 29, 25Took on a new financial obligation+2 more in the same filing8-K 2.03 ↗
- Aug 15, 25A material agreement was terminated+3 more in the same filing8-K 1.02 ↗
- Jul 24, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jul 10, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jun 27, 25Took on a new financial obligation+3 more in the same filing8-K 2.03 ↗
- May 21, 25Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- May 15, 25A senior executive left or was appointed8-K 5.02 ↗
3 material agreements entered2024 – 2025show all 3hide
- Apr 15, 25Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Apr 9, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Nov 1, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Jul 19, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
7 older filings not shown · The record reaches back to Jun 23, 10.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Jan 18, 22A debt obligation was accelerated+2 more in the same filing8-K 2.04 ↗
- May 25, 21A debt obligation was accelerated+2 more in the same filing8-K 2.04 ↗
- Nov 19, 20A debt obligation was accelerated+2 more in the same filing8-K 2.04 ↗
- May 12, 20A debt obligation was accelerated+2 more in the same filing8-K 2.04 ↗
- Feb 19, 20A debt obligation was accelerated+2 more in the same filing8-K 2.04 ↗
- Mar 8, 19A debt obligation was accelerated+4 more in the same filing8-K 2.04 ↗
- Nov 27, 18A debt obligation was accelerated+4 more in the same filing8-K 2.04 ↗
- Jun 1, 18A debt obligation was accelerated+3 more in the same filing8-K 2.04 ↗
- Mar 21, 16Past accounts declared unreliable and being restated+2 more in the same filing8-K 4.02 ↗
The full record holds 9 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- PAULSON & CO. INC.19.1%Aug 14, 25SCHEDULE 13D/A ↗2 earlier filings
- Alex Meruelo10.0%Mar 31, 25SCHEDULE 13D ↗
- Icahn Capital LP9.4%May 20, 25SCHEDULE 13D/A ↗10 co-filers on this document — the figure is the largest single stake, not their sum.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Steven A. Tananbaum9.5%Jun 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
- NOMURA HOLDINGS INC4.2%Sep 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Aug 19, Lenar Aimee J. filed notice of intent to sell up to $259K. It is filed under a scheduled plan (10b5-1), arranged in advance.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $259K on Aug 19, per their Form 4. That is 100% of the shares announced so far, and the window is still open.
Stock compensation, tax and giftsshow the 35 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Sep 30, 26Compensation$7KAMY B WECHSLER↗
- Sep 30, 26Compensation$34KSANDRA LEUNG↗
- Sep 30, 26Compensation$62KJohn Paulson↗
- Jul 17, 26Tax$25KAimee J. LenarPresident, US Pharma↗
- Jul 15, 26Tax$114KAimee J. LenarPresident, US Pharma↗
- Jul 14, 26Tax$15KSTEVEN HYOSIG LEESVP, Controller & CAO↗
- Jun 30, 26Compensation$34KSANDRA LEUNG↗
- Jun 30, 26Compensation$62KJohn Paulson↗
- Jun 30, 26Compensation$7KAMY B WECHSLER↗
- May 22, 26Compensationamount n/aChristian A Garcia↗
- May 22, 26Compensationamount n/aMICHAEL GOETTLER↗
- May 22, 26Compensationamount n/aSARAH B KAVANAGH↗
- May 22, 26Compensationamount n/aFrank D. Lee↗
- May 22, 26Compensationamount n/aSANDRA LEUNG↗
- May 22, 26Compensationamount n/aJohn Paulson↗
- May 22, 26Compensationamount n/aROBERT N POWER↗
- May 22, 26Compensationamount n/aEIRY ROBERTS↗
- May 22, 26Compensationamount n/aAMY B WECHSLER↗
- Mar 31, 26Compensation$7KAMY B WECHSLER↗
- Mar 31, 26Compensation$62KJohn Paulson↗
- Mar 31, 26Compensation$32KSANDRA LEUNG↗
- Mar 2, 26Tax$498KTHOMAS APPIOChief Executive Officer↗
- Mar 2, 26Other$6.8MTHOMAS APPIOChief Executive Officer↗
- Mar 2, 26Tax$101KSeana CarsonEVP, General Counsel↗
- Mar 2, 26Other$821KSeana CarsonEVP, General Counsel↗
- Feb 27, 26Tax$493KTHOMAS APPIOChief Executive Officer↗
- Feb 27, 26Tax$156KSeana CarsonEVP, General Counsel↗
- Feb 27, 26Tax$291KJean-Jacques CharhonEVP, CFO↗
- Feb 26, 26Tax$704KTHOMAS APPIOChief Executive Officer↗
- Feb 26, 26Tax$217KJean-Jacques CharhonEVP, CFO↗
- Feb 26, 26Tax$195KSeana CarsonEVP, General Counsel↗
- Feb 26, 26Tax$106KAimee J. LenarEVP, US Pharma↗
- Feb 25, 26Compensationamount n/aTHOMAS APPIOChief Executive Officer↗
- Feb 25, 26Compensationamount n/aJean-Jacques CharhonEVP, CFO↗
- Feb 25, 26Compensationamount n/aSeana CarsonEVP, General Counsel↗
The full record holds 210 transactions and goes back to Dec 30, 22.
Its sector and its market
Bausch Health Companies Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Bausch Health Companies Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Bausch Health Companies Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 2,049 documents on file, from May 22, 1996 to Oct 2, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.